Acute Coronary Syndromes (ACS)

heartwire News

Perspective

  • When to Stent in Stable CAD? That Is (Still) the Question   Drs Harrington, Maron, and Patel discuss the ORBITA trial, which compared coronary stenting with sham percutaneous coronary intervention for angina relief. Why did ORBITA cause so much buzz?
  • Revascularization in CS: Keep It Simple and Get Out of Dodge   Drs Harrington, Batchelor, and O'Donoghue discuss the implications of the TCT late-breaking CULPRIT SHOCK trial testing culprit-only vs multivessel revascularization in unstable patients in cardiogenic shock.
  • AHA Ushering in a New Era of Disease Prediction Dr Mandrola attended a young investigators award session and reports on the future of risk prediction--which means knowing our DNA.
  • AHA Mandrola Previews AHA 2017 The American Heart Association Scientific Sessions begin in Anaheim November 11. Learn which updates Dr Mandrola is most looking forward to.